When was MANKIND PHARMA LIMITED incorporated?

MANKIND PHARMA LIMITED was incorporated on Jul 03, 1991. It is registered with the Registrar of Companies, Delhi, and its current company status is Active.

What is the Corporate Identification Number (CIN) of MANKIND PHARMA LIMITED?

MANKIND PHARMA LIMITED's Corporate Identification Number (CIN) is L74899DL1991PLC044843.

What is the registered address of MANKIND PHARMA LIMITED?

The registered address of MANKIND PHARMA LIMITED is 208, Okhla Industrial Estate, Phase-III, South Delhi, New Delhi, Delhi, India, 110020.

What is the latest employee count at MANKIND PHARMA LIMITED?

As of Jun 30, 2025, the latest employee count at MANKIND PHARMA LIMITED is 19,532.

Does MANKIND PHARMA LIMITED have any loans on it?

MANKIND PHARMA LIMITED has taken out 37 loans from the financial institutions State Bank of India, ICICI BANK LIMITED and CATALYST TRUSTEESHIP LIMITED, with a total disclosed borrowing of over ₹11,800Cr. The largest loan was ₹2,500Cr from CATALYST TRUSTEESHIP LIMITED in Nov 2024, followed by others ranging from ₹2Cr to ₹1,250Cr between Sep 2018 and Nov 2025.

Who are the authorized signatories of MANKIND PHARMA LIMITED?

As of Sep 2026, the authorized signatories of MANKIND PHARMA LIMITED include Ramesh C Juneja, Ashutosh Dhawan and Satish Kumar Sharma.

MANKIND PHARMA LIMITED - 2026 Company Profile, Financials & Shareholding

Name: MANKIND PHARMA LIMITED
Brand: MANKIND PHARMA LIMITED
Price: 3.38 USD

MANKIND PHARMA LIMITED is a Public Limited Company and was incorporated on Jul 03, 1991 in India. It is registered at Registrar of Companies, ROC Delhi. Its registered address is 208, Okhla Industrial Estate, Phase-III, South Delhi, New Delhi, Delhi, India, 110020. Its corporate identification number is (CIN) L74899DL1991PLC044843 and its current status is Active. It has 29 GST numbers registered across 24 states. These include 37AAACM9401C1ZU in Andhra Pradesh (active) and 18AAACM9401C1ZU in Assam (active). As of Sep, 2026, all 29 GST numbers are active. Its industry classification as per MCA is other Business Activities. It had a team size of 19532 employees as on Jun 30, 2025.

MANKIND PHARMA LIMITED's last Annual General Meeting (AGM) was held on Aug 07, 2025 as per records from Ministry of Corporate Affairs (MCA). MANKIND PHARMA LIMITED's authorised share capital is ₹422Cr and its paid up capital is ₹41.3Cr. The current board of directors of MANKIND PHARMA LIMITED comprises Ramesh C Juneja, Satish Kumar Sharma and 6 more.

MANKIND PHARMA LIMITED generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2026.

Key Metrics

CIN

L74899DL1991PLC044843

Location

India

Current Status

Active

Entity Type

Public Limited Company

Date Of Incorporation

Jul 03, 1991

Company Age

35 Years 2 Months

Registrar of Companies

ROC - Delhi

Last AGM Date

Aug 07, 2025

Latest Revenue

₹1,000+ Cr as on Mar 31, 2026

Latest Employee Count

19,532 as on Jun 30, 2025

Authorized Capital

₹422Cr

Paid Up Capital

₹41.3Cr

Email: *****@mankindpharma.com, *****@mankindpharma.com
Registered Address: 208, Okhla Industrial Estate, Phase-III, South Delhi, New Delhi, Delhi, India, 110020

There are 4 brands associated with MANKIND PHARMA LIMITED which includes Mankind , Mankind Group Family office , Manforce Condoms and Mediforce Healthcare .

Name	Short Description	Founded Year	Location	Current Stage
Mankind	Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations	1991	India	Public
Mankind Group Family office	Single family office of Mankind Group	-	India	Unfunded
Manforce Condoms	Online platform offering a variety of premium condoms	2007	India	Unfunded
Mediforce Healthcare	Pharmaceutical company that manufactures and distributes a range of medicines and healthcare products	2011	India	Unfunded

View more details on MANKIND PHARMA LIMITED's profile

The majority of MANKIND PHARMA LIMITED's turnover comes from Wholesale and retail trade; repair of motor vehicles and motorcycles.

Main Activity Group Code	Description of Main Activity	Business Activity Code	Description of Business Activity	Turnover Percentage
G	Wholesale and retail trade; repair of motor vehicles and motorcycles	46	Wholesale trade, except of motor vehicles and motorcycles	{jw
C	Manufacturing	21	Manufacture of basic pharmaceutical products and pharmaceutical preparations	kkq
N	Administrative and support service activities	82	Office administrative, office support and other business support activities	zij

Filing Summary

Here is a summary of filing activity and document availability across financial years:

File Type	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Financial Statements
Annual Returns

Latest Financials, Share Allotment and Annual Report

The latest filed financial documents, annual reports, and share allotment filings are shown below:

Changes to Capital Structure

Buy Now

Recent Filings

Below are the most recent filings submitted by the company:

Document Name	Category	Filing Date
Form MGT-6	Other eForm Documents	Apr 16, 2026
Form MGT-6	Other eForm Documents	Apr 07, 2026
Form PAS-3	Other eForm Documents	Mar 19, 2026
Optional attachment(s)- if any	Other eForm Documents	Mar 19, 2026
Optional attachment(s)- if any	Other eForm Documents	Mar 19, 2026
Optional attachment(s)- if any	Other eForm Documents	Mar 19, 2026
List of Allottees	Other eForm Documents	Mar 19, 2026
Form MGT-6	Other eForm Documents	Mar 16, 2026
CERTIFICATE OF SATISFACTION OF CHARGE	Certificates	Mar 05, 2026
Form CHG-4	Charges	Mar 05, 2026

To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins

MANKIND PHARMA LIMITED generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of MANKIND PHARMA LIMITED has a compounded annual growth rate (CAGR) of 15% in the last 1 year.

Financial Statement Summary

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22
Income Statement
Revenue	7961	7367	7319	1881	3872
Total Sales	1159	7463	3976	5033	3615
Total Expenses	3264	1569	7846	6280	6820
Operating Expenses	4291	7790	5837	4864	5812
Employee Expenses	4381	6893	5030	7663	7187
Marketing Expenses	8816	8377	9220	2815	1013
Operating Income (EBIT)	8586	7648	7060	7681	6967
Interest Expenses	9193	6940	3584	9112	7656
Expenses from other activities	7980	2542	2451	2445	7749
Information Technology Expenses	4255	3495	6693	4094	2533
EBITDA	6201	8408	8390	7146	1589
Taxes	1902	1584	8868	6353	8688
Net Profit	1138	8357	6869	1728	1512
Balance Sheet
Assets	2885	1004	6674	5549	1390
Cash Equivalent	3626	2914	7560	2002	2103
Accounts Receivables	8576	9694	7045	7672	4122
Inventory	5111	2090	2551	1215	5304
Liabilities	7445	7022	4480	6845	4357
Total Debt	7924	4244	6205	1289	2738
Accounts Payable	6263	8024	2918	3688	9076
Equities	6461	6347	3583	7614	2336
Cashflow Statement
Cash from Operating activities	9162	8704	4564	3123	1545
Cash from Investing activities	6373	8677	6687	1475	2609
Net cash from Financing activities	1875	4487	6309	7759	6202

To access detailed financial performance and data, Buy Financial Report FY 26 Available

Ratios

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22
Profitability Ratios
EBITDA Margin	1224	1240	1856	4389	1947
EBIT Margin	2270	7030	2959	8824	4008
Net Profit Margin	2191	7785	5564	1992	2812
Return on Assets (ROA)	6124	3010	1621	9342	7497
Return on Equity (ROE)	4003	9740	3185	1017	5037
Return on Capital Employed	3945	8893	9581	2082	9462
Return on Invested Capital	3543	5851	8038	3234	4132
Efficiency Ratios
Asset Turnover	8064	4101	3734	3133	1813
Receivables Turnover	9681	4219	3800	6456	1475
Days Sales Outstanding	3622	1854	5754	2293	6238
Inventory Turnover	5510	6972	8002	5894	8130
Days Inventory Outstanding	7643	9624	8658	2656	4825
Payables Turnover	7835	5530	7522	8094	1179
Days Payables Outstanding	3835	3907	3721	9687	6227
Liquidity Ratios
Current Ratio	7105	6771	6922	2755	4225
Quick Ratio	5088	4203	7800	9512	9619
Cash Ratio	7228	1025	4374	9452	9080
Coverage Ratios
Cash Flow Coverage Ratio	7069	2588	6029	3738	7521
Debt Ratios
Debt-to-Equity Ratio	5873	4829	4831	8636	8137
Debt Ratio	9972	7345	1887	5446	3647
Net Debt	7932	3147	7040	6877	7118
Interest Coverage Ratio	9018	6289	5163	2008	6507
Debt Service Coverage Ratio	9509	9758	9931	6082	1688
Net Debt/EBITDA	2259	6227	3895	3419	6664
Growth Ratios
Revenue Growth Rate (CAGR)	5019	8246	6430	9663	3743
Earnings Growth Rate (CAGR)	8599	6705	6210	3570	2084

To access detailed financial performance and data, Buy Financial Report FY 26 Available

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Compounded Annual Growth Rate of MANKIND PHARMA LIMITED

Revenue CAGR	Growth
1 Year	15%
3 Year	726
5 Year	365

EBITDA CAGR	Growth
1 Year	9%
3 Year	116
5 Year	808

Disclaimer

There are 4 delayed MSME payments recorded for MANKIND PHARMA LIMITED during Oct 2024 - Mar 2025.

Here are the details of MSME payment delays for this period:

Supplier Name	Supplier PAN	Amount Due	Due since
INDUSTR IAL AUTOMA TION SYSTEMS	5882	6633	4326
PHARMA TECH INDUSTR IES	1964	6334	7347
CIMS MEDICA INDIA PVT LTD	7670	8441	6834
Indian Platinum Pvt Ltd	8880	8193	5977

To access detailed supplier-wise and period-wise MSME payment delay information,

MANKIND PHARMA LIMITED has taken 37 loans.

Here is a list of loans and charges on MANKIND PHARMA LIMITED:

As a Borrower

Loan/ Charge ID	Lender Name	Loan Amount	Status	Creation Date	Closure Date
101202514	CITI BANK N.A.	₹106Cr	fhyfggi	Nov 24, 2025	lmvluvd
101019765	ICICI BANK LIMITED	₹10Cr	jinubia	Dec 06, 2024	bvvslun
101014556	ICICI BANK LIMITED	₹30Cr	vppw{lu	Nov 20, 2024	jk{uktq
101005946	CATALYST TRUSTEESHIP LIMITED	₹2,500Cr	odlxbsi	Nov 14, 2024	adldqhc
101005942	CATALYST TRUSTEESHIP LIMITED	₹1,250Cr	gwolizv	Nov 14, 2024	ladurkg
101005947	CATALYST TRUSTEESHIP LIMITED	₹1,250Cr	{iqyisd	Nov 14, 2024	qgfbfqy
100997549	State Bank of India	₹300Cr	jkdnktn	Oct 14, 2024	{luuodj
101001826	CATALYST TRUSTEESHIP LIMITED	₹2,500Cr	zpuqqny	Oct 10, 2024	{aiobtn
101001827	CATALYST TRUSTEESHIP LIMITED	₹1,250Cr	vthilaa	Oct 10, 2024	zlaa{r{
101001824	CATALYST TRUSTEESHIP LIMITED	₹1,250Cr	aukyeur	Oct 10, 2024	eidpuja
100955659	KOTAK MAHINDRA BANK LIMITED	₹3.5Cr	qsecpci	Jul 10, 2024	z{nwemv
100952851	KOTAK MAHINDRA BANK LIMITED	₹2Cr	hsfvbr{	Jul 10, 2024	e{qokdb
100839353	ICICI BANK LIMITED	₹200Cr	sayykjr	Dec 26, 2023	hvmyelj
100652628	HDFC BANK LIMITED	₹35Cr	enqepen	Dec 01, 2022	jqhsnba
100548331	HDFC BANK LIMITED	₹100Cr	lxhyweo	Feb 24, 2022	ejpaseh
100439267	KOTAK MAHINDRA BANK LIMITED	₹200Cr	mlnhxtc	Mar 30, 2021	qfcltj{
100414619	HDFC BANK LIMITED	₹100Cr	entphkp	Jan 07, 2021	ujkrhq{
100401490	HDFC BANK LIMITED	₹355Cr	jqefwhx	Dec 11, 2020	{hgmjgl
100211107	HDFC BANK LIMITED	₹15Cr	oaiuynm	Sep 07, 2018	aklrv{l
100204700	CITICORP FINANCE (INDIA) LIMITED	₹295Cr	fss{dqr	Sep 06, 2018	atrehfp

To access detailed information on a company’s loans, borrowings, & registered charges,

Founders (largest shareholder) own 60.07%, Enterprises own 8.00% and Other People own 31.93%. The net worth of MANKIND PHARMA LIMITED's founders is INR 541Cr as of Apr 23, 2007.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	60.07%	541Cr	2234364	7745451	4522572	2032658
Ramesh C Juneja	3355823	9359210	8339816	4372019	3042712	2509079
Rajeev Juneja	4726284	6070756	3728264	5626404	5197756	2694344
Enterprise	8.00%	72Cr	7986745	2037694	8439236	6110705
Other People	31.93%	287Cr	5394976	6237310	2231492	2836773
Total	100.00%	900Cr	5347109	9402544	3883147	3104280

To access the complete ownership breakdown, Buy Cap Tables

Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.

Board of Directors of MANKIND PHARMA LIMITED

Here is the list of current board of directors of MANKIND PHARMA LIMITED:

Name	Designation	Status	Appointment Date	Duration
Ramesh C Juneja	Whole-time Director	Current	May 15, 2014	12 Years 4 Months
Satish Kumar Sharma	Whole-time Director	Current	Sep 23, 2016	10 Years
Bharat Anand	Director	Current	Sep 29, 2018	8 Years
Tilokchand Punamchand Ostwal	Director	Current	Sep 29, 2020	6 Years
Sheetal Arora	Whole-time Director	Current	May 20, 2021	5 Years 4 Months
Rajeev Juneja	Managing Director	Current	May 20, 2021	5 Years 4 Months
Vivek Kalra	Director	Current	Aug 01, 2022	4 Years 1 Month
Vijaya Sampath	Director	Current	Aug 01, 2022	4 Years 1 Month

To access detailed information on a company’s board members, directors, & authorized signatories,

Signatories of MANKIND PHARMA LIMITED

Here is the list of current signatories of MANKIND PHARMA LIMITED:

Name	Designation(s)	Status	Appointment Date	Duration
Ramesh C Juneja	Whole-time Director	Current	May 15, 2014	12 Years 4 Months
Ashutosh Dhawan	CFO	Current	Jun 17, 2016	10 Years 3 Months
Satish Kumar Sharma	Whole-time Director	Current	Sep 23, 2016	10 Years
Bharat Anand	Director	Current	Sep 29, 2018	8 Years
Tilokchand Punamchand Ostwal	Director	Current	Sep 29, 2020	6 Years
Rajeev Juneja	Managing Director	Current	May 20, 2021	5 Years 4 Months
Sheetal Arora	Whole-time Director	Current	May 20, 2021	5 Years 4 Months
Vivek Kalra	Director	Current	Aug 01, 2022	4 Years 1 Month
Vijaya Sampath	Director	Current	Aug 01, 2022	4 Years 1 Month
Hitesh Kumar Jain	Company Secretary	Current	Jan 20, 2025	1 Year 8 Months

To access detailed information on a company’s board members, directors, & authorized signatories,

Cross Directorships of MANKIND PHARMA LIMITED

MANKIND PHARMA LIMITED has directors who also hold positions in 44 other legal entities. The top 20 are listed below:

Legal Entity Name	% of Common Directors	Common Director(s)	Open Charge(s)	Active Legal Case(s)
Mankind Pharma Limited CIN: L74899DL1991PLC044843, India, Active	482	784	159	706
BHARAT SERUMS AND VACCINES LIMITED CIN: U74110MH1993PLC075088, India, Active	588	219	591	504
BHARAT SERUMS AND VACCINES LIMITED CIN: U74110MH1993PLC075088, India, Active	540	261	668	618
MAGNET LABS PRIVATE LIMITED CIN: U51397DL1998PTC093307, India, Amalgamated	844	362	950	893
PAVI BUILDWELL PRIVATE LIMITED CIN: U70200DL2012PTC237294, India, Active	504	633	251	946
JASPACK INDUSTRIES PRIVATE LIMITED CIN: U36912DL2015PTC277915, India, Amalgamated	559	592	654	734
APPIAN PROPERTIES PRIVATE LIMITED CIN: U24100DL2017PTC321898, India, Active	776	978	812	943
MANKIND CONSUMER PRODUCTS PRIVATE LIMITED CIN: U21002DL2024PTC430710, India, Active	408	923	640	638
LIFESTAR PHARMA PRIVATE LIMITED CIN: U24232DL2004PTC131232, India, Amalgamated	746	406	482	236
APPIAN ASSOCIATES INFRASTRUCTURE PRIVATE LIMITED CIN: U45201HR2006PTC052011, India, Active	218	850	344	665
MANKIND BIOTECH PRIVATE LIMITED CIN: U74999DL2017PTC325426, India, Active	782	855	841	167
APPIAN MULTIVENTURES PRIVATE LIMITED CIN: U70100DL2013PTC251212, India, Active	940	863	662	490
ANM PROPERTIES PRIVATE LIMITED CIN: U70109DL2016PTC307317, India, Active	870	265	609	526
Craftsman Automation Limited CIN: L28991TZ1986PLC001816, India, Active	851	655	454	944
VA TECH WABAG LIMITED CIN: L45205TN1995PLC030231, India, Active	908	265	890	736
GYAN INFRASTRUCTURE COMPANY PRIVATE LIMITED CIN: U70101DL1997PTC085909, India, Active	234	357	604	501
ROCKMAN INDUSTRIES LIMITED CIN: U35921PB1981PLC004729, India, Active	150	278	386	512
SYRMA JOHARI MEDTECH LIMITED CIN: U45201RJ1995PLC009997, India, Active	438	721	341	197
JK PAPER LIMITED CIN: L21010GJ1960PLC018099, India, Active	484	338	807	196
MAX FINANCIAL SERVICES LIMITED CIN: L24223PB1988PLC008031, India, Active	125	988	583	704

To access detailed information on a company’s board members, directors, & authorized signatories,

MANKIND PHARMA LIMITED has an employee count of 19532 as on Jun 30, 2025.

Employee count trend for MANKIND PHARMA LIMITED

Date	Employee Count
Jun 25	19532
May 25	918
Apr 25	649
Mar 25	468
Feb 25	219
Jan 25	983
Dec 24	335

Media has covered brands linked with MANKIND PHARMA LIMITED for a total of 23 events in the last 1 year, 8 of them have been about company updates and 3 about partnerships.